Neuro-Symbolic Models for Explaining Epidemic Dynamics (EpiXplain)
Official title: SCH: Neuro-Symbolic Models for Explaining Epidemic Dynamics (EpiXplain)
Funded at Georgia State University · NIH-11576345 · Data updated 2026-11-12
A new modeling framework will blend AI reasoning with symbols to help explain and forecast how diseases spread, considering biology, behavior, mobility, and interventions relevant to patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 18, 2026 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $296,231 |
| NIH project number | 1R01AI206606-01 |
| Project ID | NIH-11576345 on NIH RePORTER |
Who could benefit from this research
✓Could help
This research is aimed at informing strategies that affect patients and the public, particularly in outbreaks of communicable diseases.
✕Less likely to help
Patients not directly involved in an active outbreak or those not impacted by the studied interventions may see limited immediate benefit.
What this research studies
This project creates EpiXplain, a causal neuro-symbolic model to untangle why epidemics unfold the way they do, by blending data from biology, human behavior, and public-health actions. Researchers will build multi-modal data methods and interpretable models to make epidemic predictions clearer for decision-makers. The work aims to connect complex data streams to understandable explanations that could inform patient-facing guidance and community responses. The project will develop robust simulation and optimization tools to explore how different interventions might influence disease spread.
Why it matters
Potential benefit: If successful, this work could improve how public health decisions are communicated and how interventions protect patients and communities.
How similar studies have gone: Previous approaches often lacked full integration of biology, behavior, and mobility, making this project’s integrated approach both novel and potentially more impactful.
Where this research is happening
-
Georgia State University
Atlanta, United States Active
Researchers
- Principal investigator: Chowell, Gerardo — Georgia State University
- Study coordinator: Chowell, Gerardo
Related research
Other NIH-funded projects on the same topics.
-
Exploring how Neisseria gonorrhoeae uses nutrients and host sugars to thrive
A study to understand how the gonorrhea bacteria grab nutrients from the human host and how it interacts with sugars on our cells to help design better treatments.
-
Environmental and sanitation improvements with a smartphone app
A low-cost smartphone tool helps US cities and households report sanitation problems to prevent illness and costly repairs.
-
Vaccine study in mice to protect against gonorrhea using a new OMV-based approach
Researchers are testing an OMV-based vaccine in mouse models to block Neisseria gonorrhoeae infection by targeting key bacterial proteins.
-
Vaccine design to protect against future coronaviruses
A new vaccine concept aims to protect people by targeting multiple coronavirus lineages likely to cause future pandemics.
-
Frataxin's role in protecting the liver from MASLD-related injury
This grant studies how a mitochondrial helper protein, frataxin, affects liver damage in people with MASLD (a common liver disease), with the aim of finding new ways to prevent or reduce injury.
-
A T cell vaccine approach to prevent Dengue and Zika infections
A new vaccine approach aims to teach the immune system’s T cells to recognize and fight Dengue and Zika viruses without triggering harmful antibody responses.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.